专栏名称: 毕凯今选
由毕凯医药为您每周跟踪PUBMED十大瘤种最新前沿进展,编译制作,每日分享推送,希望我们的一点点绵薄之力,能为临床助力,做医生的朋友,做患者的帮助!
目录
相关文章推荐
51好读  ›  专栏  ›  毕凯今选

【其他高分选 073】

毕凯今选  · 公众号  ·  · 2024-11-01 15:43

正文

BC

PMID: 39441940

IF:11.7

Single-cell chemoproteomics identifies metastatic activity signatures in breast cancer


SCI:Sci Adv

PMID:39442522

IF:27.7

Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex


SCI:Cell Metab

PMID:39442887

IF:12.8

5alpha-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort study


SCI:J Am Acad Dermatol

PMID:39446324

IF:10.5

Racial Disparities in Receipt of Guideline-Concordant Care in Older Adults With Early Breast Cancer


SCI:JAMA Netw Open

PMID:39446322

IF:10.5

Regional Variation in Deescalated Therapy in Older Adults With Early-Stage Breast Cancer


SCI:JAMA Netw Open

PMID:39445844

IF:10.9

Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities


SCI:Med Res Rev

PMID:39447607

IF:14.8

Association of Medicaid Expansion With Timely Receipt of Treatment and Survival Among Patients With HR-Negative, HER2-Positive Breast Cancer


SCI:J Natl Compr Canc Netw

PMID:39448199

IF:10.3

AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization


SCI:J Immunother Cancer

PMID:39448577

IF:14.7

Osteopontin is a therapeutic target that drives breast cancer recurrence


SCI:Nat Commun

PMID:39450648

IF:10.6

CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis


SCI:Brain

PMID:39454125

IF:42.1

Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer


SCI:J Clin Oncol

PMID:39460487

IF:13

Profiling Breast Tumor Heterogeneity and Identifying Breast Cancer Subtypes Through Tumor-Associated Immune Cell Signatures and Immuno Nano Sensors


SCI:Small

PMID:39455848

IF:23.5

Phase separation rewires chromatin in breast cancer


SCI:Nat Cancer

PMID:39462900

IF:15.8

A Machine Learning-Optimized System for Pulsatile, Photo- and Chemotherapeutic Treatment Using Near-Infrared Responsive MoS(2)-Based Microparticles in a Breast Cancer Model


SCI:ACS Nano

PMID:39467215

IF:42.1

Growing Evidence for the Role of Air Pollution in Breast Cancer Development


SCI:J Clin Oncol

PMID:39470686

IF:10

Integrating molecular imaging and transcriptomic profiling in advanced HER2-positive breast cancer receiving trastuzumab emtansine (T-DM1): an analysis of the ZEPHIR clinical trial


SCI:Clin Cancer Res

PMID:39471713

IF:12.8

Biologically logic-gated Trojan-horse strategy for personalized triple-negative breast cancer precise therapy by selective ferroptosis and STING pathway provoking


SCI:Biomaterials

PMID:39475614

IF:11.7

Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer


SCI:Sci Adv

PMID:39474658

IF:15.8

Tumor-Derived Extracellular Vesicles Enable Tumor Tropism Chemo-Genetherapy for Local Immune Activation in Triple-Negative Breast Cancer


SCI:ACS Nano

PMID:39472583

IF:14.7

Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope


SCI:Nat Commun

PMID:39480488

IF:13.3

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels


SCI:J Clin Invest

PMID:39479442

IF:12.4

Tumor-derived EV miRNA signatures surpass total EV miRNA in supplementing mammography for precision breast cancer diagnosis


SCI:Theranostics

PMID:39478118

IF:23.5

Defining the transcriptional lineages of breast cancer subtypes


SCI:Nat Cancer

PMID:39478117

IF:23.5

Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages


SCI:Nat Cancer

PMID:39478112

IF:58.7

Mapping metastatic breast cancer complexity through single-cell and spatial profiling


SCI:Nat Med

PMID:39478111

IF:58.7

A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features


SCI:Nat Med



CRC

PMID: 39440640

IF:10

Bioengineered Extracellular Vesicles Delivering siMDM2 Sensitize Oxaliplatin Therapy Efficacy in Colorectal Cancer


SCI:Adv Healthc Mater

PMID: 39442888

IF:10.5

A pH and glutathione-responsive carbon monoxide-driven nano-herb delivery system for enhanced immunotherapy in colorectal cancer


SCI:J Control Release

PMID: 39467291

IF:19.6

Projected Impact and Cost-Effectiveness of Novel Molecular Blood-Based or Stool-Based Screening Tests for Colorectal Cancer


SCI:Ann Intern Med

PMID: 39471815

IF:27.7

Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth


SCI:Cell Metab

PMID: 39478120

IF:23.5

Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis


SCI:Nat Cancer

PMID: 39478119

IF:23.5

Global loss of promoter-enhancer connectivity and rebalancing of gene expression during early colorectal cancer carcinogenesis


SCI:Nat Cancer



GC

PMID: 39447131

IF:14.3

HCP5 Derived Novel Microprotein Triggers Progression of Gastric Cancer through Regulating Ferroptosis


SCI:Adv Sci (Weinh)

PMID: 39473903

IF:10.7

Reduced intestinal-to-diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinoma


SCI:MedComm (2020



HCC

PMID:39439426

IF:14

Urgent Need for Education on Hepatocellular Carcinoma Surveillance Among High-Risk Population in China


SCI:Clin Mol Hepatol

PMID:39441934

IF:11.7

Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice


SCI:Sci Adv

PMID:39450426

IF:14.3

Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m6A-Modification Promotes Lenvatinib Resistance in HCC


SCI:Adv Sci (Weinh)

PMID:39455893

IF:27.7

Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma


SCI:Nat Immunol

PMID:39473907

IF:10.7

N6-methyladenosine reader YTHDF3-mediated zinc finger protein 41 inhibits hepatocellular carcinoma progression by transcriptional repression of Snail


SCI:MedComm (2020)

PMID:39472692

IF:13.7

METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma


SCI:Cell Death Differ

PMID:39479454

IF:12.4

DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma


SCI:Theranostics



LC

PMID:39440703

IF:20.1

IL2-mediated modulation of small extracellular vesicles secretion and PD-L1 expression: a novel perspective for neutralizing immune suppression within cancer cells


SCI:Cancer Commun (Lond)

PMID:39443184

IF:18.8

Clean air actions can conquer the growing burden of lung cancer with population aging in China


SCI:Sci Bull (Beijing)

PMID:39446493

IF:13.3

Non-classical action of Ku70 promotes Treg suppressive function through a FOXP3-dependent mechanism in lung adenocarcinoma


SCI:J Clin Invest

PMID:39468367

IF:31.7

Obesity-dependent selection of driver mutations in cancer


SCI:Nat Genet

PMID:39470734

IF:16.6

EGFR-mediated HSP70 phosphorylation facilitates PCNA association with chromatin and DNA replication


SCI:Nucleic Acids Res

PMID:39470424

IF:12.1

Predicting Recurrence after Sublobar Resection in Patients with Lung Adenocarcinoma Using Preoperative Chest CT Scans


SCI:Radiology

PMID:39475952

IF:15.7

Diagnosis of Respiratory Sarcopenia for Stratifying Postoperative Risk in Non-Small Cell Lung Cancer


SCI:JAMA Surg

PMID:39475596

IF:11.7

Ex vivo modeling of precision immuno-oncology responses in lung cancer


SCI:Sci Adv

PMID:39475541

IF:15.8

Targeted Positron Emission Tomography-Tracked Biomimetic Codelivery Synergistically Amplifies Ferroptosis and Pyroptosis for Inducing Lung Cancer Regression and Anti-PD-L1 Immunotherapy Efficacy


SCI:ACS Nano







请到「今天看啥」查看全文